Predicting node positivity in gastric cancer from gene expression profiles.

Area of Science:

• Oncology
• Molecular Biology
• Genomics

Background:

• Lymphovascular invasion (LVI) is a prognostic indicator in gastric cancer, often assessed via biopsy.
• Endoscopic biopsies allow for both LVI assessment and gene expression profiling.

Purpose of the Study:

• To investigate gene expression patterns associated with LVI in gastric cancer.
• To develop a gene expression-based predictor of tumor aggressiveness and nodal positivity (N+).

Main Methods:

• Analysis of gene expression profiles from gastric cancer patient cohorts.
• Development of a 28-gene signature to predict tumor aggressiveness.
• Correlation of the gene signature's aggressiveness ranking with nodal positivity (N+).

Main Results:

• A significant positive correlation was found between the 28-gene model's tumor aggressiveness ranking and N+ status.
• The gene expression model demonstrated a stronger correlation with N+ status than LVI alone.
• The model's predictive capability for tumor aggressiveness was statistically significant.

Conclusions:

• A 28-gene signature can predict gastric cancer aggressiveness and nodal positivity.
• This gene expression-based approach may offer a more accurate pre-operative risk assessment tool than LVI.
• Gene expression profiling from endoscopic biopsies holds promise for personalized gastric cancer management.